{"name":"Janssen Korea, Ltd., Korea","slug":"janssen-korea-ltd-korea","ticker":"","exchange":"","domain":"janssenkoreakorea.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"immunology","drugs":[{"name":"Fentanyl matrix","genericName":"Fentanyl matrix","slug":"fentanyl-matrix","indication":"Other","status":"marketed"},{"name":"Fentanyl D-trans","genericName":"Fentanyl D-trans","slug":"fentanyl-d-trans","indication":"Other","status":"marketed"},{"name":"Oxybutynin chloride OROS","genericName":"Oxybutynin chloride OROS","slug":"oxybutynin-chloride-oros","indication":"Other","status":"marketed"},{"name":"Propranolol booster","genericName":"Propranolol booster","slug":"propranolol-booster","indication":"Other","status":"marketed"},{"name":"Topiramate Slow","genericName":"Topiramate Slow","slug":"topiramate-slow","indication":"Other","status":"marketed"},{"name":"Tramadol Hydrochloride Plus Acetaminophen","genericName":"Tramadol Hydrochloride Plus Acetaminophen","slug":"tramadol-hydrochloride-plus-acetaminophen","indication":"Other","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Hydromorphone HCI OROS","genericName":"Hydromorphone HCI OROS","slug":"hydromorphone-hci-oros","indication":"Moderate to severe pain","status":"phase_2"},{"name":"Hydromorphone HCl OROS","genericName":"Hydromorphone HCl OROS","slug":"hydromorphone-hcl-oros","indication":"Moderate to severe chronic pain requiring around-the-clock opioid therapy","status":"marketed"},{"name":"Tramadol HCl/Acetaminophen IR","genericName":"Tramadol HCl/Acetaminophen IR","slug":"tramadol-hcl-acetaminophen-ir","indication":"Moderate to moderately severe pain","status":"phase_3"},{"name":"Tramadol HCl/acetaminophen Extended Release","genericName":"Tramadol HCl/acetaminophen Extended Release","slug":"tramadol-hcl-acetaminophen-extended-release","indication":"Moderate to moderately severe pain (chronic pain management)","status":"marketed"},{"name":"Tramadol hydrochloride/ Acetaminophen","genericName":"Tramadol hydrochloride/ Acetaminophen","slug":"tramadol-hydrochloride-acetaminophen","indication":"Moderate pain","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Risperidone long acting injectables","genericName":"Risperidone long acting injectables","slug":"risperidone-long-acting-injectables","indication":"Schizophrenia","status":"marketed"},{"name":"Paliperdidone ER","genericName":"Paliperdidone ER","slug":"paliperdidone-er","indication":"Schizophrenia","status":"marketed"},{"name":"Topiramate Standard","genericName":"Topiramate Standard","slug":"topiramate-standard","indication":"Epilepsy / seizure disorders","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"decitabine injection","genericName":"decitabine injection","slug":"decitabine-injection","indication":"Myelodysplastic syndromes (MDS)","status":"marketed"}]}],"pipeline":[{"name":"Hydromorphone HCI OROS","genericName":"Hydromorphone HCI OROS","slug":"hydromorphone-hci-oros","phase":"phase_2","mechanism":"μ-opioid receptor agonist","indications":["Moderate to severe pain"],"catalyst":""},{"name":"Fentanyl matrix","genericName":"Fentanyl matrix","slug":"fentanyl-matrix","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Risperidone long acting injectables","genericName":"Risperidone long acting injectables","slug":"risperidone-long-acting-injectables","phase":"marketed","mechanism":"Risperidone blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood.","indications":["Schizophrenia","Bipolar I disorder (maintenance treatment)","Irritability associated with autism spectrum disorder"],"catalyst":""},{"name":"decitabine injection","genericName":"decitabine injection","slug":"decitabine-injection","phase":"marketed","mechanism":"Decitabine is a DNA methyltransferase inhibitor that reduces DNA methylation, reactivating silenced tumor suppressor genes and promoting differentiation and apoptosis in myelodysplastic cells.","indications":["Myelodysplastic syndromes (MDS)","Acute myeloid leukemia (AML)"],"catalyst":""},{"name":"Fentanyl D-trans","genericName":"Fentanyl D-trans","slug":"fentanyl-d-trans","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hydromorphone HCl OROS","genericName":"Hydromorphone HCl OROS","slug":"hydromorphone-hcl-oros","phase":"marketed","mechanism":"Hydromorphone HCl OROS is an opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and is formulated as an extended-release osmotic system for sustained pain relief.","indications":["Moderate to severe chronic pain requiring around-the-clock opioid therapy"],"catalyst":""},{"name":"Oxybutynin chloride OROS","genericName":"Oxybutynin chloride OROS","slug":"oxybutynin-chloride-oros","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paliperdidone ER","genericName":"Paliperdidone ER","slug":"paliperdidone-er","phase":"marketed","mechanism":"Paliperidone ER is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms.","indications":["Schizophrenia","Schizoaffective disorder","Bipolar I disorder (acute and maintenance treatment)"],"catalyst":""},{"name":"Propranolol booster","genericName":"Propranolol booster","slug":"propranolol-booster","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Topiramate Slow","genericName":"Topiramate Slow","slug":"topiramate-slow","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Topiramate Standard","genericName":"Topiramate Standard","slug":"topiramate-standard","phase":"marketed","mechanism":"Topiramate blocks sodium channels and enhances GABA-mediated inhibition in the central nervous system to reduce neuronal excitability.","indications":["Epilepsy / seizure disorders","Migraine prophylaxis","Bipolar disorder (off-label)"],"catalyst":""},{"name":"Tramadol HCl/Acetaminophen IR","genericName":"Tramadol HCl/Acetaminophen IR","slug":"tramadol-hcl-acetaminophen-ir","phase":"phase_3","mechanism":"Tramadol HCl/Acetaminophen IR is a combination of a centrally acting opioid analgesic and a non-opioid analgesic that works by affecting the central nervous system to relieve pain.","indications":["Moderate to moderately severe pain","Severe pain"],"catalyst":""},{"name":"Tramadol HCl/acetaminophen Extended Release","genericName":"Tramadol HCl/acetaminophen Extended Release","slug":"tramadol-hcl-acetaminophen-extended-release","phase":"marketed","mechanism":"Tramadol inhibits norepinephrine and serotonin reuptake while acting as a weak opioid agonist, and acetaminophen reduces pain through central analgesic and antipyretic effects.","indications":["Moderate to moderately severe pain (chronic pain management)"],"catalyst":""},{"name":"Tramadol Hydrochloride Plus Acetaminophen","genericName":"Tramadol Hydrochloride Plus Acetaminophen","slug":"tramadol-hydrochloride-plus-acetaminophen","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tramadol hydrochloride/ Acetaminophen","genericName":"Tramadol hydrochloride/ Acetaminophen","slug":"tramadol-hydrochloride-acetaminophen","phase":"marketed","mechanism":"Tramadol inhibits norepinephrine and serotonin reuptake while acting as a weak opioid agonist, and acetaminophen reduces pain through central analgesic and antipyretic effects.","indications":["Moderate pain"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1ldFF3MmNaMGppdXhtaHZxY25iQWp1SEd1SkJldWY1MzJSQzNSQnZsaDUxdmNEeDBfTmJLRENnV0o4T25peUJlR1NjaUFHdW5MMU54aTdUeTZXVlZfZVZ0cGlYb1BaT0pCM0gtS2VR0gFyQVVfeXFMUDdmaURuNy1seG1oVmlSeUM3VWw4T3NzWWduNGR6NmNLck9sZzVtaTMtUUIxTUhPazhRMnY4eHBhM2pZV3FuWWVWVkpJWFlFUVhjeURISTdjQ0pra1FWc1ZLMGtxMzlHQzhXcmhoMDNKNF9R?oc=5","date":"2025-11-13","type":"pipeline","source":"koreabiomed.com","summary":"Janssen Korea to shut Incheon vaccine plant, putting 230 jobs at risk - koreabiomed.com","headline":"Janssen Korea to shut Incheon vaccine plant, putting 230 jobs at risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQekM2YmdaSHh0N3NmSXRHenRmTlFKOXROT0dvOGlwRFBha2ppTXVEdVc5VjdYdE5vWVl6MklGYkdWaTNSNDR5cXU2SUdDMnFlX3F3UUw5aE1KT0ktSjRWaWljQlVqQUtoR3RUSklxcVRwaS1JX3pVMmxDSnZtc2NVbi1tZEZjUEotV3dTV2VZbXJicVNrY1ZEVzg3SDgtNzRGc2VfaW5CRWNiajNiQTVlREhERzFYc05mRWFEdERn?oc=5","date":"2025-09-24","type":"regulatory","source":"BioSpace","summary":"FDA Hits J&J With Warning Letter Over ‘Significant Violations’ at Korean Production Plant - BioSpace","headline":"FDA Hits J&J With Warning Letter Over ‘Significant Violations’ at Korean Production Plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNVUlCRmx6VUpGbDF5ekJsdWxDSnpGa2tFT1Fkbk9DcUhlc082REZtWFF4MVNCb0pVeWlSQVlyLTZuNFNoRXljTDVOM0xuakFtWW1FVmxzc053UzZzSmRfYnNaaGlCcjFObWVnNklURFkzTW8yQXBfSjdTUHFyUVp4Vkk1eTdSRk9xX0VpTTNoYWRMSFZRQ19XZDdLZUxoYnVrcWRCTGhaa25BZW5kOVB3SjljOWR3RVpoS1Y1bXlNd214OHNz?oc=5","date":"2025-09-23","type":"regulatory","source":"Fierce Pharma","summary":"FDA hands warning letter to J&J subsidiary over stopper issues, spotty reporting at Korean plant - Fierce Pharma","headline":"FDA hands warning letter to J&J subsidiary over stopper issues, spotty reporting at Korean plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE13Rk1DMXZsSWFyb25TTUUxRTBhc0s0WlBJZElocm5raWZrZi1zT2pyakloc3F1Zk5jNmpPdGM1ZEVjZGxzOGV1aUgzNkF4cWVRN0lYSzE0ZnZ1YXVOUll4VG81dDJwRl9LZXRVaHpn0gFyQVVfeXFMT3BGa1VTdXkxV0xhNGZfYWs1ZGJIYmQ4c2tSU3VqZHVoQ2trQ1g5MDQ3cUlvak1yT1cyMFo1MUROTU1YbGxhS3lKUm83ZTNEMVI1aWN4RmNrcV8yeFdLSUdZZmpURWVjWXlULWVGd1lQRlhR?oc=5","date":"2025-07-02","type":"pipeline","source":"koreabiomed.com","summary":"Kuhnil Pharm appoints former Takeda Korea head Moon Hee-seok as co-CEO - koreabiomed.com","headline":"Kuhnil Pharm appoints former Takeda Korea head Moon Hee-seok as co-CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5HYUdFUFBuWTEtVjExVHdpbGliQ1lqajdhUjByT3lneGpaQWZsRnppNnZRaWhMZXJyaU1Zbmx5dThSOHZkQ2s4VnlRWWRlUnBFcmFzMzAyZUdBX2lFem8ybERMdk9nTEpHOE9xcXVB0gFyQVVfeXFMTURtcW91cnhQUmdZb1o5amVQbjhvS29qRlU1MG9xdkNhSFVpUmY3SHktUWQ1NExYcGRrZXFhUHpLdl8yS19KS0cxTFNaQzZUc2ZHaU1uNk5ETVFvdEdoSUc2WXdrRmJlcGNDaEpCTnh3Qnln?oc=5","date":"2025-05-27","type":"pipeline","source":"koreabiomed.com","summary":"Samjin Pharmaceutical appoints former Janssen GM as president - koreabiomed.com","headline":"Samjin Pharmaceutical appoints former Janssen GM as president","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9pN3BqZi1uVDNNajVxY05WWEpfbVRjb2UtM0x1NHdfdXZLNEZ0YnhIaU9vOVBSVTFuSHZrXzJUSHVlSEJzcE9Wa1NneXFQM2dNZU50ZmFOMGk2c3JaRU9mYXJlcjR0cGMwR0ZrZUtB0gFyQVVfeXFMTXdwczJoNHJsT1E1ZEEtNnZNemNIcC1HN3NGOGllVGtmWUhTUThXdy0wSFJMLXY0VktXVTdSSENmRDFjbzRpSFlOa0dLYzFvSzV6UThjS09aY1N2YTdTanFzdnJuXzkyRks5TUtmU3lObUln?oc=5","date":"2023-10-23","type":"deal","source":"koreabiomed.com","summary":"Janssen Korea celebrates 40 years of innovation, pledging growth through collaboration - koreabiomed.com","headline":"Janssen Korea celebrates 40 years of innovation, pledging growth through collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5uVjkzN2lRUEc2ZG92c1pGTXBfUk9VeThCOXJCQkVKcWFpZWVjNUE5b3JlR2RScjljRng0QU54SHByU2JmSzJaQ0xsOFJQUjh6M1J2WFM2MmFCOXdfVTRDUVBTMEh1TG5yWlloc2x30gFyQVVfeXFMTW0wclJmZVhRN3BSU1BmYm42VTZINUJBZ3pyVzlnc1RHaEVjM2RpZkRJaGFKRjJKQnJSVDY4dmh0MGxJVkppbGR0RW5EQURySEV0VEpOWnNLNmpab3htXzRHR2JrOFFvaFE0RU94MEh2RmtB?oc=5","date":"2022-03-22","type":"pipeline","source":"koreabiomed.com","summary":"Janssen discontinues drug manufacturing in Korea - koreabiomed.com","headline":"Janssen discontinues drug manufacturing in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE02SHhtcTV6UTU3VEg0MkFiSWZQbGpiMXJSVzZBWHZldmtYUXNZSzlVZmR4SUJKVEJHU1BsOXptVHZQTjkxZ3RiVTZMUTZOLWhDY1MzZjBxOVc0UFRVVUJyag?oc=5","date":"2020-08-03","type":"pipeline","source":"Pharmaceutical Executive","summary":"Country Report: Korea - Pharmaceutical Executive","headline":"Country Report: Korea","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-06-30","type":"deal","source":"PR Newswire","summary":"Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge for Healthcare in the New Normal in Collaboration with Seoul Metropolitan Government and Kor","headline":"Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge for Healthca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQdTNrTVBwVjlqVFZtZmZuTjhSeVN5ZXJyZ0FNNEVrbWxwMFJhUG94a19jR1VSLXAtM1B1WUszeG5JeXpEekUtbUpfWTNXQW9NWlVhdEdIY09LRWhhdy1kcGdQX1FkU1RXb0ZOdzdPM0VrRUxWVFpNMUZBWXh2cmhDM195ZlFMYlhqLXR1WWR2T3VKbjQ?oc=5","date":"2018-11-06","type":"pipeline","source":"Fierce Biotech","summary":"Janssen taps South Korea’s Yuhan for Tagrisso rival - Fierce Biotech","headline":"Janssen taps South Korea’s Yuhan for Tagrisso rival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOeXpjYk1qRkw1TGtZVWFiaEI5SGZmb3JHaTlGUzZnYjJWYWlLc28zamRINmhjRjJ2UmVBeEdTSjRGYVlLQVJoWEZSWWZvMjUzVHVmajZoS2xMQmtQV2tPUDllRUtlY0pPbGYxdzUwNzlfWjBGTUlHSy1RTVpLOWdHYWRoeS1zQk14dm90RW4tS1NPdmY3b2FWckV5RlpaYWRnbjR6Yg?oc=5","date":"2018-08-09","type":"pipeline","source":"BioPharma Dive","summary":"J&J, Bayer to shutter production plants in South Korea: report - BioPharma Dive","headline":"J&J, Bayer to shutter production plants in South Korea: report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNZEowRzJfeVoyOHR6R2FidTRiS1dvMldNLUpmbFRQa2toRDlETGRCNWg0VWRQYk5xUXEtOGxrVUx2NzVyQ3JoUnJfZ3BzeVpQRUU3eG8xS1FtaGZOSXRPalFDYUl6a0g4SVVaOWRIZnZ1Qklpb0I2eFMxRTlMWmRTSi1HdjRMcW93YXA5dmw2ZDluMnU0RHFyNWthX09fTzVUWWF2TUd0X0FNT08tYW1ZVkpaaGctRVJyX2c?oc=5","date":"2018-08-03","type":"regulatory","source":"Fierce Pharma","summary":"Janssen, Bayer to close South Korean plants due to limited demand - Fierce Pharma","headline":"Janssen, Bayer to close South Korean plants due to limited demand","sentiment":"neutral"}],"patents":[],"drugCount":15,"phaseCounts":{"phase_2":1,"marketed":13,"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}